Does Non-Small Cell Lung Cancer Histologic Type Influence Outcomes with Single-Fraction Stereotactic Body Radiotherapy?

被引：0
|
作者：
Videtic, G. [1 ]
Reddy, C. [1 ]
Woody, N. [1 ]
Stephans, K. [1 ]
机构：
[1] Cleveland Clin, Radiat Oncol, Cleveland, OH 44106 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P05.02
引用
收藏
页码：S982 / S982
页数：1
相关论文
共 50 条
  • [21] Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy
    Klement, Rainer J.
    Sonke, Jan-Jakob
    Allgaeuer, Michael
    Andratschke, Nicolaus
    Appold, Steffen
    Belderbos, Jose
    Belka, Claus
    Dieckmann, Karin
    Eich, Hans T.
    Flentje, Michael
    Grills, Inga
    Eble, Michael
    Hope, Andrew
    Grosu, Anca L.
    Semrau, Sabine
    Sweeney, Reinhart A.
    Hoerner-Rieber, Juliane
    Werner-Wasik, Maria
    Engenhart-Cabillic, Rita
    Ye, Hong
    Guckenberger, Matthias
    RADIOTHERAPY AND ONCOLOGY, 2020, 142 : 210 - 216
  • [22] Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer
    Steber, Cole R.
    Hughes, Ryan T.
    Soike, Michael H.
    Helis, Corbin A.
    Nieto, Karina
    Jacobson, Travis
    Nagatsuka, Moeko
    McGinnis, Hamilton S.
    Leyrer, C. Marc
    Farris, Michael K.
    ACTA ONCOLOGICA, 2021, 60 (05) : 605 - 612
  • [23] Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
    Ze-Tian Shen
    Xin-Hu Wu
    Bing Li
    Xi-Xu Zhu
    Medical Oncology, 2015, 32
  • [24] Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
    Shen, Ze-Tian
    Wu, Xin-Hu
    Li, Bing
    Zhu, Xi-Xu
    MEDICAL ONCOLOGY, 2015, 32 (03)
  • [25] No Difference in Outcomes for Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Pathologic Diagnosis
    De Leo, A. N.
    Braschi, E. L.
    Morris, C. G.
    Yeung, A. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E434 - E434
  • [26] Lung Function Changes Post Stereotactic Body Radiotherapy Treatment for Non-Small Cell Lung Cancer
    Kern, J. A.
    Carr, L. L.
    Slatore, C. G.
    Farris, M.
    Swanson, S.
    Smith, C.
    Stone, K.
    Wisnivesky, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Does Central vs. Peripheral Tumor Location Impact Outcomes Following Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer?
    Park, H. S.
    Harder, E.
    Mancini, B. R.
    Decker, R. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S28 - S29
  • [28] DOSIMETRIC PREDICTORS OF TOXICITY AND LOCAL CONTROL OF SINGLE-FRACTION SABR FOR NON-SMALL CELL LUNG CANCER
    Bouchard, Myriam
    Caron, Anthony
    Turgeon, Guy-Anne
    Provencher, Sawyna
    Lavoie-Gagnon, Heloise
    Amzallag, Daniel
    Soucy, Isabelle
    Lemaire-Paquette, Samuel
    Plourde, Marc-Emile
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S20 - S20
  • [29] The Effect of Stereotactic Body Radiotherapy (SBRT) Dose-Fraction (fx) Schema on Non-Small Cell Lung Cancer (NSCLC)
    Pirlamarla, M. K.
    Deng, M.
    Yankey, H. N.
    Dougherty, T.
    Handorf, E.
    Kumar, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E49 - E49
  • [30] Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer
    Alcibar, Olwen Leaman
    Nadal, Ernest
    Palomar, Inmaculada Romero
    Navarro-Martin, Arturo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 529 - 538
12345